Shah NN, Colina AS, Johnson BD, Szabo A, et al. Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma. J Clin Oncol 2025 Mar 31:JCO2402158. doi: 10.1200/JCO-24-02158.
PMID: 40163793